2026-020 Announcement on Using Part of the Proceeds Providing Entrusted Loans to a Wholly-owned Subsidiary for Investment Projects Funded by the Proceeds
2025-043 Announcement on the Approval of the Registration for the Application for the Private Issuing of A-shares by the China Securities Regulatory Commission
2025-024 Announcement on the Extension of the Validity Period of the Shareholders' Meeting Resolution and Related Authorizations for Private Issuing of A-shares
2024-040 Suggestive Announcement on Completion of Principal and Interest Payment and Delisting of EB Issued by Controlling Shareholders and the Proposed Cancellation
2024-020 Announcement of Risk Warnings regarding Dilution of Immediate Return Arising from the Private Issuing of A-shares and Remedial Measures taken by the Company and the Undertakings made by the Relevant Parties.DOC
2024-018 Announcement that there is no Financial Assistance or Indemnity to Investors who Participate in the Subscription Directly or Through Stakeholders when Issuing Private Placement
2024-016 The Annucement of Statement of Reasons that the Company is not Required to Prepare the Report on the Use of Proceeds from the Previous Fund Raising Activity
2023-014 Announcement on Participating in the 2022 Annual and 2023 Q1 Collective Results Presentation of Listed Companies under SinoChem Holdings Co., Ltd.
2021-026 Announcement on the Completion of Industrial and Commercial Change Registration of Free Equity Transfer of China National Chemical Corporation Ltd.
2019-029 Announcement on guarantee and trust registration of some A-shares held by the controlling shareholders for issuing exchangeable corporate bonds
2018-012 Announcement of Establishment of AVF Professional Private Equity Investment Fund by Controlling Subsidiary of Bluestar Adisseo Company and Seventure Partners
